Applying Manuka Honey in Gastroenterology - Manuka and GI disorders

TweeSteden ziekenhuis0 个研究点目标入组 60 人开始时间: 待定最近更新: 2024年2月28日

适应症

试验速览

暂无简介。

•All patients seen at the outpatient clinic in either Elisabeth-TweeSteden Hospital in Tilburg, or the Maastricht University Medical Center with any of the following diagnoses will be eligible for inclusion: ;1. Patients with a persistent clostridium difficile infection who either do not respond to antibiotic therapy or do not tolerate antibiotics;2. Patients with diagnosed microscopic colitis who have received maximum budesonide treatment, and experience relapse of symptoms during step-down dosages, defined as budesonide dependent microscopic colitis ;3. Patients diagnose with irritable bowel syndrome patients of diarrhea subtype according to the Rome IV criteria, whose symptoms persist despite 6 months of treatment via the outpatient clinic ;- Therapy refractory defined as patients with a definitive diagnosis who continue to have a defecation frequency above 3 times daily, with at least one of these times a consistency of 5 or 6 according to the Bristol Stool Scale. ;- A minimum of 1 year follow up;- Age older than 18 years old at diagnosis

•- Patients younger than 18 years of age ;- Comorbidities of gastro-intestinal tract;- Drug or alcohol abuse

发起方

TweeSteden ziekenhuis